Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin versus gabapentin for attenuation of intubation hemodynamic response during CABG surgery
IRCT20240929063203N9Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in coronary arteriosclerosis comparing Melatonin, Gabapentin and Placebo (3 arms). Primary endpoints: Systolic blood pressure, Diastolic blood pressure and 2 more. Started May 2026; status: completed.
02
Drugs
melatoningabapentin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20240929063203N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240929063203N9.